bullish
(Mostly Asia) M&A in 2018: What Was Hot, And What Was Not
911 Views07 Jan 2019 23:57
This insight briefly summarises the 93 M&A transactions, with a collective deal size of ~US$215bn, published on Smartkarma in ...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Takeda Pharmaceutical (4502 JP): Bearish Tone Continues Despite New Drug Approvals23 Dec 2021
- Takeda Pharmaceutical (4502 JP): Recent Pipeline Blues Puts a Brake on Stock Recovery15 Oct 2021
- Takeda Pharma Bear Press Below 3,58019 Oct 2020
- (Mostly Asia) M&A in 2018: What Was Hot, And What Was Not07 Jan 2019
x